Skip to content

Medical Grand Rounds: The Mass General Story of IgG4-related Disease

In This Article

  • The Division of Rheumatology, Allergy, and Immunology at Massachusetts General Hospital presented at a recent virtual Medical Grand Rounds
  • John Stone, MD, MPH, Cory Perugino, DO, and Guy Katz, MD, each discussed various aspects of IgG4-related disease
  • Topics included the disease's major clinical manifestations, ongoing clinical trials, adaptive immune response, and more

On May 18, 2023, a virtual Department of Medicine Medical Grand Rounds presentation was led by the Division of Rheumatology, Allergy, and Immunology at Massachusetts General Hospital.

The panel included John Stone, MD, MPH, the Edward A. Fox Chair in Medicine and director of clinical trials in rheumatology at Mass General, Cory Perugino, DO, assistant physician in the division, and Guy Katz, MD, research fellow in the division.

Dr. Stone reflected on the history of IgG4-related disease at Mass General, including major clinical manifestations and ongoing clinical trials. Dr. Perugino reviewed the most up-to-date knowledge regarding the disease's adaptive immune response, and Dr. Katz discussed the potential role of the complement system in IgG4-related disease.

Watch the video »

Learn about the IgG4-Related Systemic Disease Program at Mass General

Refer a patient to the Division of Rheumatology, Allergy, and Immunology

Related topics


A Massachusetts General Hospital rheumatologist is leading efforts to recognize and treat previously misdiagnosed and misunderstood IGg4-related systemic disease.


Massachusetts General Hospital is conducting an NIH-funded clinical trial exploring elotuzumab as a treatment for IgG4-related disease.